Gyre Therapeutics, Inc. · NASDAQ:GYRE

Ye Weiguo sold 34,976 Gyre Therapeutics, Inc. shares (Form 4)

Traded Jun 4 to Jun 5, 2026 · Filed Jun 8, 2026

From Jun 4 to Jun 5, 2026, Ye Weiguo (Chief Operating Officer) sold 34,976 Gyre Therapeutics, Inc. shares at an average US$6.25 for US$219K, leaving 700,000 shares. Filed Jun 8, 2026 (Form 4).

Sold: 34,976 shares
Price: US$6.25 average (US$6.13 to US$6.40)
Value: US$219K
Holding after: 700,000 shares
Trading plan: No
Role: Chief Operating Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Jun 4, 2026	Common Stock	Option exercise	19,575	US$0.75	719,575	Direct
Jun 4, 2026	Common Stock	Sale	19,575	US$6.13	700,000	Direct
Jun 5, 2026	Common Stock	Option exercise	15,401	US$0.75	715,401	Direct
Jun 5, 2026	Common Stock	Sale	15,401	US$6.40	700,000	Direct

Source

View original at SEC

Related